Brief: Immuno-Oncology Company Portage Biotech Completes Monetization of Intensity Therapeutics Shares
26/03/2024 12:14
March 26 (Reuters) - Portage Biotech:
* PORTAGE BIOTECH COMPLETES MONETIZATION OF INTENSITY
THERAPEUTICS
(INTS) SHARES
* PORTAGE BIOTECH INC - COMPANY WILL USE PROCEEDS TO FURTHER
FUND
ITS PORT-6 PHASE 1A PORTION OF ADPORT-601 TRIAL
Source text for Eikon: ID:nGNXb9VZb1
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsAlpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
Brief: Alpha Compute Signs Binding Gpu Contract, Leasing ALPHA-03 Cluster Under Four-Year, $81.7 Million Agreement In Its Missouri Superintelligence Factory
Alpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview